HashDash Logo

CBGA

What is CBGA? In this chapter, we discuss the compound known as the ”mother of all cannabinoids”, and review its effects and potential medical benefits.

Chapter 6 · 4 min read
CBGA

What is CBGA?

Nicknamed the mother cannabinoid, CBGA, or cannabigerolic acid, is a significant, arguably major cannabinoid with significant potential for medical applications with low risk of mild, temporary side effects.

CBGA is the most important and foundational cannabinoid found in cannabis. All major cannabinoids, including THC, CBD, and CBC, ultimately descend from CBGA. CBGA creates THCA, CBDA, and CBCA, among others, which are decarboxylated into the neutral forms we are more familiar with.

CBGA gives rise to the diversity of cannabinoids and chemotypes we have today by acting as the “mothership cannabinoid”. When CBGA remains dominant in a cannabis plant, without converting to the other acidic cannabinoids, it’s called type IV cannabis chemotype by researchers. Type IV cannabis is a major type of hemp, right behind type III cannabis (CBDA dominant).

CBGA.jpg

Cannabis plants can now be selectively bred up to 100% CBGA or CBDA hemp. Manufacturers must be extra careful during the extraction process, because any amount of heat will degrade the CBGA into CBG. Logically, there isn't enough CBGA in other chemotypes because it’s already been converted almost entirely into THCA or CBDA, respectively.

Effects of CBGA

CBGA is non-impairing because it has a weak affinity for CB1 (psychoactive) and CB2 receptors. Instead, it generally acts in the background on many other receptor targets that are important for regulating mood (as CBG), inflammation, pain, and metabolism. It also indirectly influences endocannabinoid system enzymes (e.g. DAGL, MAGL) that may increase feel-good endocannabinoids.

CBGA is available in legal hemp-based products, and open to public use for a variety of health and wellness reasons. People who are busy, working, or otherwise active during the daytime can take advantage of CBGA’s non-intoxicating relief without concern of getting high. Since CBGA quickly turns into CBG after smoking, baking, and even simply after ingestion, they inevitably share many effects as they enter the body.

Dr. Abraham Benavides's profile

What the expert says...

Dr. Abraham Benavides

"CBGA is the direct parent of CBG and all major cannabinoid acids (e.g. THCA, CBDA, CBCA). It’s the grandparent of THC, CBD, and CBC. Thus, CBGA’s properties closely reflect those of CBG."

Potential Benefits of CBGA

There isn’t any clinical research yet conducted on important minor cannabinoids like CBGA or even CBDA. In fact, CBGA is one of the least studied or known cannabinoids, despite its foundational importance.

According to the CannaKeys database, there are less than a total of 50 animal (in vivo), test tube (in vitro), and computer-based (in silico) studies that provide hints about this compound’s potential healing properties and medical applications.

In sum, according to limited evidence, the potential benefits of CBGA include:

  • Anti-inflammatory
  • Antioxidant
  • Pain relieving (mostly as CBG)
  • Potential role in controlling diabetes
  • Improving fat metabolism (lipids)
  • Improving cardiac use of sugars (increase glucose metabolism via inhibiting aldolase reductase)
  • By extension, the above combined features may help prevent heart disease
  • Anticancer effects on colon cancer polyps and leukemia cell types (additive with CBD)
  • Neuromodulatory and neuroprotective
  • Possible role in skin diseases
  • Antiviral, blocking SARS-CoV-2 from entering cells (via blocking spike proteins)

Based on metabolism and body heat, it's also reasonable to assume that CBGA gives near-identical potential effects to CBG.

Potential Side Effects of CBGA

Since there aren't any clinical studies on CBGA, we don't know the full set of possible short or long-term side effects. However, we do know that cannabinoids like CBG have a great safety profile and are generally well-tolerated with few side effects to worry about.

Because of CBGA’s quick conversion to CBG upon consumption, it's reasonable to assume that you may experience side effects similar to CBG, such as:

  • Increased appetite
  • Dry mouth and eyes
  • Tiredness or sleepiness
  • Dizziness or lightheadedness

To date, there aren’t any serious side effects reported from CBGA.

What We Learned: CBGA

CBGA is of major importance, but ironically is among the least-studied cannabinoids. There are few preclinical studies to demonstrate findings, but they are encouarging. Here’s what we learned about CBGA:

  • Nicknamed the mother cannabinoid, CBGA, or cannabigerolic acid, is a rare cannabinoid with significant potential for medical applications.
  • Like CBG, CBGA is non-impairing and does not get you high.
  • During the growth cycle, CBGA is produced early in the life cycle, in cannabis trichomes, and helps the plant maximize energy to grow healthy flowers.
  • CBGA converts into major cannabinoids via a chain reaction of THCA, CBDA, and CBCA.
  • Some studies provide some hints about this compound’s potential therapeutic properties in treating inflammation, neurological disorders, heart disease, metabolic disorders, skin diseases, COVID-19, and some cancers.

If you are loving gaining more knowledge of cannabinoids, what better way to do so than to continue learning about these compounds right here in our guide? Answer the question below, and let’s inch closer to completion of this guide.

Citations
  1. Blesching, U. (2020, September 27). Cannabis Chemotypes. Cannakeys.https://cannakeys.com/cannabis-chemotypes/
  2. Blesching, U. (2022). Cannabigerolic Acid (CBG-a) Cannabinoid Research. Cannakeys.https://cannakeys.com/cannabigerolic-acid-cbg-a-cannabinoid-research/
  3. Calapai, F., Cardia, L., Esposito, E., Ammendolia, I., Mondello, C., Lo Giudice, R., Gangemi, S., Calapai, G., & Mannucci, C. (2022). Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives. Evidence-Based Complementarhttps://doi.org/10.1155/2022/3336516
  4. Cascio, M., Gauson, L., Stevenson, L., Ross, R., & Pertwee, R. (2010). Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. British Journal of Pharmacology, 159(1), 12https://doi.org/10.1111/j.1476-5381.2009.00515.x
  5. Di Meo, C., Tortolani, D., Standoli, S., Angelucci, C. B., Fanti, F., Leuti, A., Sergi, M., Kadhim, S., Hsu, E., Rapino, C., & Maccarrone, M. (2022). Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. International Jouhttps://doi.org/10.3390/ijms23105430
  6. Formato, M., Crescente, G., Scognamiglio, M., Fiorentino, A., Pecoraro, M. T., Piccolella, S., Catauro, M., & Pacifico, S. (2020). (‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research. Molecules, 2https://doi.org/10.3390/molecules25112638
  7. Janecki, M., Graczyk, M., Lewandowska, A. A., & Pawlak, Ł. (2022). Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. International Journal of Molecular Sciences, 23(8), 4170.https://doi.org/10.3390/ijms23084170
  8. Jastrząb, A., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2022). The Origin and Biomedical Relevance of Cannabigerol. International Journal of Molecular Sciences, 23(14), 7929.https://doi.org/10.3390/ijms23147929
  9. Nachnani, R., Raup-Konsavage, W. M., & Vrana, K. E. (2021). The Pharmacological Case for Cannabigerol. Journal of Pharmacology and Experimental Therapeutics, 376(2), 204–212.https://doi.org/10.1124/jpet.120.000340
  10. Russo, E. B., Cuttler, C., Cooper, Z. D., Stueber, A., Whiteley, V. L., & Sexton, M. (2022). Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannhttps://doi.org/10.1089/can.2021.0058
  11. van Breemen, R. B., Muchiri, R. N., Bates, T. A., Weinstein, J. B., Leier, H. C., Farley, S., & Tafesse, F. G. (2022). Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. Journal of Natural Products, acs.jnatprod.1c00946.https://doi.org/10.1021/acs.jnatprod.1c00946
  12. Walsh, K. B., McKinney, A. E., & Holmes, A. E. (2021). Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Frontiers in Pharmacology, 12, 777804.https://doi.org/10.3389/fphar.2021.777804

Test your knowledge, track your progress and earn your badge.

Chapter Question

What is CBGA often referred to as?

Share
Was this chapter helpful?
Dr. Abraham Benavides
Medically reviewed by

Dr. Abraham Benavides

Dr. Abraham Benavides is an internationally-recognized cannabis research expert, experienced medical advisor, and full-tuition merit scholar of the George Washington University School of Medicine and Health Sciences. Dr. Abe enjoys helping patients as a writer, educator, and cannabis health coach at the GW Center for Integrative Medicine.

Compare

 

Category

Dominant Terpene

Chemotype

THC %

Positive Effects

Negative Effects

Alleviates Symptoms

Helps with

Welcome to HashDash

Are you 21 or older?

By accessing this site, you accept the

Terms and Conditions

and

Privacy Policy